Meeting
2023 ASCO Annual Meeting
PSMA PET guided salvage radiotherapy among patients with prostate cancer in the post-prostatectomy setting: A single center post-hoc analysis.
Authors
Clayton P Smith
UCLA Department of Radiation Oncology, Los Angeles, CA
Clayton P Smith , Wesley Robert Armstrong , Kevyn J Clark , Jonathan Moore , Makayla Roberts , Andrea Farolfi , Robert Evan Reiter , Matthew Rettig , John Shen , Luca Valle , Nicholas George Nickols , Michael L. Steinberg , Johannes Czernin , Amar Upadhyaya Kishan , Jeremie Calais
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Hormone-Sensitive
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5009)
DOI
10.1200/JCO.2023.41.16_suppl.5009
Abstract #
5009
Poster Bd #
103
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud
Poster
2023 ASCO Genitourinary Cancers Symposium
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: A post hoc analysis of the PROPS trial.
First Author: Samuel Tremblay
Poster
2021 ASCO Annual Meeting
Diagnostic performance of Gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging in early-relapsed prostate cancer: Phase 3, prospective, multicenter study (IAEA-PSMA study).
First Author: Juliano J Cerci
Poster
2017 Genitourinary Cancers Symposium
The CHAPPP study: Changing care with PSMA-PET for Prostate cancer—A retrospective study of the role of PSMA imaging in altering treatment pathways.
First Author: Andrew Schmidt